Key result
Metabolically unhealthy obesity linked to ~476% higher odds of elevated insulin resistance versus healthy obesity.
Why the study?
Findings regarding metabolic differences between metabolically healthy and unhealthy obesity remain inconsistent, and data are lacking in understudied populations with high obesity prevalence.
Cross-Sectional (n=450)
Yes
While metabolically healthy obesity is associated with a more favorable inflammatory and insulin resistance profile than metabolically unhealthy obesity, it still exhibits significant adipose tissue dysfunction and low-grade inflammation compared to normal weight individuals.
Answers are grounded in this paper and cite their sources.
Distinguishes cardiometabolic profiles within obesity; cross-sectional data leave prospective outcome implications open.
Obesity is a heterogeneous condition. While Metabolically Healthy Obesity (MHO) is often considered to carry a lower risk of metabolic complications than Metabolically Unhealthy Obesity (MUO), findings on their differences remain inconsistent. This study examines for the first time the metabolic differences across obesity phenotypes in Saudi adults, addressing a literature gap in understudied populations with high obesity prevalence. This cross-sectional study included 450 Saudi adults classified as MHO, MUO, or metabolically healthy normal weight (MHNW) based on BMI (≥ 30 kg/m²) and the presence of ≥ 3 metabolic abnormalities per National Cholesterol Education Program (NCEP) criteria. Anthropometric, metabolic, and inflammatory parameters were assessed. Age- and sex-adjusted logistic regression analyses were used to compare phenotypes. MUO individuals showed significantly higher adiposity indices, insulin resistance (HOMA-IR), and inflammatory markers compared to MHO individuals (p-values < 0.001). MHO individuals also differed significantly from MHNW individuals. Adiponectin levels were comparable across groups; however, the Adiponectin/Leptin ratio (adpn/lep) was lowest in the MUO group, indicating adipose tissue dysfunction. MUO individuals had increased odds of elevated HOMA-IR (OR = 5.76, p < 0.001) and CRP (OR = 2.64, p = 0.005) compared to MHO. While insulin resistance did not differ significantly between MHO and MHNW, MHO participants had higher odds of a low adpn/lep ratio (OR = 2.87, p < 0.005). MUO individuals exhibited greater metabolic risk than MHO, with marked insulin resistance and inflammation. However, the presence of adipokine imbalance and elevated inflammatory markers in MHO suggests that ‘metabolic health’ in obesity may be relative rather than absolute.
No takes yet. Share an insight, caveat, or question.
Wani et al. (2025) conducted a cross-sectional in Obesity (Metabolically Healthy vs Unhealthy) (n=450). Metabolically Unhealthy Obesity (MUO) vs. Metabolically Healthy Obesity (MHO) was evaluated on Elevated HOMA-IR (≥ 3.8) (OR 5.76, 95% CI 3.4-9.6, p=<0.001). Metabolically unhealthy obesity was associated with increased odds of elevated insulin resistance and C-reactive protein compared to metabolically healthy obesity.
Synapse has enriched 10 related papers. Consider them for comparative context: